]>
IRCT20181110041600N1 IRCT 2020-07-15 Shahid Beheshti University of Medical Sciences Evaluation of the effect of cupping on clinical symptoms of adult asthma 18-60 years The effect of wet cupping on clinical manifestation of the adult asthma 18-60 ‎years ‎ 2020-07-22 anticipated 72 Complete https://irct.ir/trial/49322 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, after calculating the final sample size of the study, random chains are generated on the basis of simple random series using quadratic random blocks for both intervention and control groups. For the generated random chain, a corresponding code will be generated for each sequence. This code contains two letters of the alphabet and one number. Anonymous codes will be posted on the forms before the study begins. During the study, patients were divided into two groups according to the order of entry of patients and randomization sheets (merely including anonymous codes). Patients in the intervention group will receive wet cupping in addition to routine treatment. Patients in the control group will receive only routine treatment. N/A Mild to moderate asthma. Intervention 1: Intervention group: The intervention group is being treated with standard asthma medications, which will use 25.25 micrograms of 2 puff serum sprays every 12 hours, and if needed, they can also use salbutamol spray with more cupping (cupping between the two shoulders) cupping in It is performed on one of the 17th, 19th and 21st lunar months. The intervention is performed only once. Each cupping period involves 3 stages of blood sampling and lasts approximately 10 minutes. Intervention 2: Control group: The control group is only treated with standard asthma medications, using a 25.25 microgram 2-puff serum spray every 12 hours, and they can also use salbutamol spray if needed. Yes - There is a plan to make this available What will be shared: Publishing results in the form of a PhD thesis and an article indexing in ISI When: after PhD thesis defence To whom: Public Conditions: for research reasons Where to obtain: Shahid Beheshti University of Medical Sciences How to obtain: approving by the responsible officer Comments:
public Abbas Joushan
Faculty of Traditional Medicine, Shahid Beheshti University of Medical Sciencesm No.8 Shams Alley, Vali-e-Asr Street
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 dr.a.joushan@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Abbas Joushan
Faculty of Traditional Medicine, Shahid Beheshti University of Medical Sciencesm No.8 Shams Alley, Vali-e-Asr Street
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 dr.a.joushan@sbmu.ac.ir Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients with mild to moderate asthma are diagnosed by a pulmonary specialist. Patients with stable conditions. The patient's age is 18 to 60 years old. 18 years 60 years Both Patients with severe asthma and need hospitalization Patients with underlying conditions such as CF, bronchopulmonary, dysplasia, heart failure, pulmonary embolism, bronchotracheomalacia, bronchiectasis, sarcoidosis, and diabetes Consumer of drugs such as aspirin, beta-blockers and NSAIDs Cupping less than a month Patients with a history of coagulation disorders Patients with a history of anemia Weak immune system Smokers Breastfeeding Pregnancy Inability to speak Persian J45 Asthma Treatment - Devices Treatment - Other Intervention group: The intervention group is being treated with standard asthma medications, which will use 25.25 micrograms of 2 puff serum sprays every 12 hours, and if needed, they can also use salbutamol spray with more cupping (cupping between the two shoulders) cupping in It is performed on one of the 17th, 19th and 21st lunar months. The intervention is performed only once. Each cupping period involves 3 stages of blood sampling and lasts approximately 10 minutes. Control group: The control group is only treated with standard asthma medications, using a 25.25 microgram 2-puff serum spray every 12 hours, and they can also use salbutamol spray if needed. Evaluation of clinical symptoms of patients with mild to moderate asthma. Timepoint: At week zero and at the end of weeks one, two, four, six and eight. Method of measurement: Asthma Control Test. Evaluation of clinical symptoms of patients with mild to moderate asthma. Timepoint: In the week of zero and at the end of the first, second, fourth, sixth and eighth weeks. Method of measurement: Asthma control questionnaire. Shahid Beheshti University of Medical Sciences Approved 2020-07-07 Ethics Committee of Shahid Beheshti University of Medical Sciences Shahid Beheshti University of Medical Sciences, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)